Story thread · 2 reports / 2 sources

Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?

247wallst.com · 3h · first reportShare

Both Amgen and Merck write quarterly checks and raise them every year, but only one has the portfolio depth to keep growing that payout through the next brutal round of patent expirations. The answer may surprise investors who have been watching Merck's blockbuster momentum.